Other
the study is observational
the study is observational is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completed
The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring
NCT03790631
unknown
Optimal Adalimumab Plasma Concentrations in Ankylosing Spondylitis Patients
NCT04875299
completed
Validation of a Multimodal Indicator of Depth of Anesthesia
NCT02742012
Clinical Trials (3)
Showing 3 of 3 trials
NCT03790631
The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring
NCT04875299
Optimal Adalimumab Plasma Concentrations in Ankylosing Spondylitis Patients
NCT02742012
Validation of a Multimodal Indicator of Depth of Anesthesia
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3